Nobivac DHPPI

Land: New Zealand

Språk: engelsk

Kilde: Ministry for Primary Industries

Aktiv ingrediens:

canine distemper virus (attenuated); canine parvovirus (attenuated); canine parainfluenza virus (attenuated); canine adenovirus type 2 (attenuated)

Tilgjengelig fra:

Schering-Plough Animal Health Limited

INN (International Name):

canine parvovirus (attenuated), canine adenovirus type 2 (attenuated), canine parainfluenza virus (attenuated), canine distemper

Sammensetning:

canine distemper virus (attenuated) 0 vaccine; canine parvovirus (attenuated) 0 vaccine; canine parainfluenza virus (attenuated) 0 vaccine; canine adenovirus type 2 (attenuated) 0 vaccine

Terapeutisk område:

Vaccine

Autorisasjon status:

ACVM Registered

Autorisasjon dato:

1991-05-16

Preparatomtale

NOBIVAC DHPPI
25 dose – Insert Card and Label
A006257
Page 1 of 5
NOBIVAC DHPPI
30-Nov-23
Insert Card – Front Cover
RESTRICTED VETERINARY MEDICINE
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
NOBIVAC
® DHPPI
25 vials of combined live attenuated freeze-dried canine distemper,
adenovirus type 2,
parvovirus and parainfluenza virus vaccine.
To be reconstituted with Nobivac Diluent or Nobivac Lepto 1.
ACVM Registration No. A006257.
25 X 1 dose
MSD Animal Health logo
Insert Card – Inside panels
DESCRIPTION
Nobivac DHPPi is a live attenuated freeze-dried vaccine offering
protection against canine
distemper, infectious hepatitis, parvovirus and parainfluenza in dogs.
Each vial (1 dose when reconstituted) contains:
•
Canine distemper virus, strain Onderstepoort

10
4
TCID
50
•
Canine adenovirus type 2, strain Manhattan LPV3

10
4
TCID
50
•
Canine parvovirus, strain C154

10
7
TCID
50
•
Parainfluenza virus, strain Cornell

10
5.5
TCID
50
The diluent (Nobivac Diluent) is phosphate buffered saline. Nobivac
Lepto 1 (A007832) may
be used as diluent.
INDICATION
Active immunisation of healthy dogs against canine distemper virus,
canine adenovirus type
1 and type 2, canine parvovirus and canine parainfluenza virus.
The puppy programme can be completed from 10 weeks of age and
following completion, the
components of Nobivac DHPPi have been shown to protect against canine
distemper virus,
canine parvovirus and canine adenovirus for at least three years. The
onset of immunity is one
week following completion of primary vaccination. For the canine
parainfluenza component,
annual vaccination is recommended. Onset of immunity is four weeks.
Nobivac DHPPi can be
used in pregnant bitches.
DOSAGE AND ADMINISTRATION
Reconstitute each single dose (vial) of the vaccine with one vial (1
mL) of Nobivac Diluent or
Nobivac Lepto 1 vaccine and administer by subcutaneous injection.
NOBIVAC DHPPI
25 dose – Insert Card and Label
A006257
Page 2 of 5
NOBIVAC DHPPI
30-Nov-23
WHEN THE VACCINE IS RECONSTITUTED WITH